Adverse drug reactions with halogenated anesthetics

被引:31
作者
Kharasch, E. D. [1 ]
机构
[1] Washington Univ, Dept Anesthesiol, Div Clin & Translat Res, St Louis, MO 63130 USA
关键词
D O I
10.1038/clpt.2008.97
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Problems with organ toxicity from the halogenated volatile anesthetics have influenced clinical practice, anesthetic selection, and drug development for half a century. 1,2 In turn, investigations that elucidated the mechanisms of volatile anesthetics adverse effects identified new mechanisms, provided remarkable insights into human toxicology, and represented seminal contributions to clinical pharmacology. This review focuses on adverse organ effects ( hepatic, renal, and others) that are attributable to anesthetic metabolism and/or degradation. Routine reversible effects on pulmonary, cardiac, and other organ functions are not addressed.
引用
收藏
页码:158 / 162
页数:5
相关论文
共 30 条
[1]   Formation and toxicity of anesthetic degradation products [J].
Anders, MW .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 :147-176
[2]   Mechanistic aspects of carbon monoxide formation front volatile anesthetics [J].
Baxter, PJ ;
Garton, K ;
Kharasch, ED .
ANESTHESIOLOGY, 1998, 89 (04) :929-941
[3]  
Bovill J. G., 2008, V182, P121, DOI 10.1007/978-3-540-74806-9_6
[4]  
CHRIST DD, 1988, DRUG METAB DISPOS, V16, P135
[5]   METHOXYFLURANE NEPHROTOXICITY - STUDY OF DOSE-RESPONSE IN MAN [J].
COUSINS, MJ ;
MAZZE, RI .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1973, 225 (13) :1611-1616
[6]   Dose-related biochemical markers of renal injury after sevoflurane versus desflurane anesthesia in volunteers [J].
Eger, EI ;
Gong, D ;
Koblin, DD ;
Bowland, T ;
Ionescu, P ;
Laster, MJ ;
Weiskopf, RB .
ANESTHESIA AND ANALGESIA, 1997, 85 (05) :1154-1163
[7]   PENTAHALOETHANE-BASED CHLOROFLUOROCARBON SUBSTITUTES AND HALOTHANE - CORRELATION OF INVIVO HEPATIC PROTEIN TRIFLUOROACETYLATION AND URINARY TRIFLUOROACETIC-ACID EXCRETION WITH CALCULATED ENTHALPIES OF ACTIVATION [J].
HARRIS, JW ;
JONES, JP ;
MARTIN, JL ;
LAROSA, AC ;
OLSON, MJ ;
POHL, LR ;
ANDERS, MW .
CHEMICAL RESEARCH IN TOXICOLOGY, 1992, 5 (05) :720-725
[8]   Identification of the enzyme responsible for oxidative halothane metabolism: Implications for prevention of halothane hepatitis [J].
Kharasch, ED ;
Hankins, D ;
Mautz, D ;
Thummel, KE .
LANCET, 1996, 347 (9012) :1367-1371
[9]   HUMAN KIDNEY METHOXYFLURANE AND SEVOFLURANE METABOLISM - INTRARENAL FLUORIDE PRODUCTION AS A POSSIBLE MECHANISM OF METHOXYFLURANE NEPHROTOXICITY [J].
KHARASCH, ED ;
HANKINS, DC ;
THUMMEL, KE .
ANESTHESIOLOGY, 1995, 82 (03) :689-699
[10]  
Kharasch ED, 2005, ANESTHESIOLOGY, V103, P1183